Skip to content
Britstake Media

Zimbabwe Rejects ‘Lopsided’ US Healthcare Assistance Agreement Because of Information Apprehensions

Medical funding image
The offered US funding was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a major American healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's request for confidential information.

This move was revealed following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".

An official spokesman later stated that the United States was requesting biological samples for research and commercial purposes but refused to guarantee the benefits from any future vaccines.

"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has called for further negotiations to find a agreement suitable to both sides so the nation's vital HIV programme can be sustained.

Wider Implications

Zimbabwe's decision follows a comparable case in Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of citizens' health data.

Since resuming office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

The agency had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and accountability.

As per statements, 16 African countries have to date agreed to these new health pacts, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Deal

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," the Ambassador added.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no equivalent guarantee of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.

"Effectively, our country would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our citizens if a future disease outbreak emerge."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining structures previously set up through the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.

"This system is designed to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."

The government's concerns regarding the US deal "are not meant as anti-American sentiment," he added.

"We encourage continued dialogue with our US partners on how subsequent co-operation might be structured in a way that honours the independence and dignity of both nations."

Health Experts Response

A leading public health body stated it acknowledged the government's concerns, but suggested that talks must proceed considering a large portion of the country's HIV programmes were funded by external financing.

"Where technical issues arise, including those involving information security or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," it added.

This impasse underscores the ongoing challenges between accepting vital foreign assistance and protecting local interests in an ever more interconnected world.

By

Mary Fritz

Oliver is a tech journalist with over 5 years of experience in consumer electronics and digital media.

Britstake Media

Type to search articles.